Jim Cole presenting to an audience

For Applicants

PITCH Participants:

  • Have access to resources, technology and expertise (including a staff of 14) for early, first steps in the drug discovery process
  • Are awarded a scope of work with all expenses paid
  • Have an opportunity to learn from other scientists, venture investors, and pharma and biotech veterans who have led large teams to develop new medicines in industry

What some of our participants are saying about PITCH:

 “We want to break the silos in academia down and get our innovations out, and have an impact on the world and on people. The PITCH program gives us an opportunity to do that using resources we wouldn’t have. What would take us 5-10 years to do will hopefully be brought down to 2-3 years because of PITCH.”

Farren Isaacs
Associate Professor of Molecular, Cellular, and Developmental Biology, Yale University

“I had been working on my investment presentation with the PITCH program for about a year when I had the opportunity to compete in a PITCH contest as part of an entrepreneurial day at Yale. I was up against 10 start ups in all sectors and there was no way I would have won if I were not part of the PITCH program.”

Jesse Rinehart
Associate Professor of Cellular and Molecular Physiology & Systems Biology Institute, Yale School of Medicine

“PITCH is the critical bridge for ideas that need a little bit of incubation and are at the interface of academia and a full-fledged venture. From a venture capital perspective, PITCH de-risks projects and for initial founders, PITCH helps us soundcheck our ideas before we go on the road.”

Ranjit Bindra
Associate Professor, Departments of Therapeutic Radiology and Experimental Patholog
Yale School of Medicine